American Regent, Inc. is recalling 74,040 vials of Levocarnitine Injection, USP (200 mg/mL), a prescription medication used to treat carnitine deficiency. The recall was initiated because some vials are missing their product labels entirely. Without a label, the medication cannot be identified, which may lead to administration errors or using the wrong drug. No incidents or injuries have been reported to date.
A missing label prevents healthcare providers from identifying the drug, strength, and expiration date, potentially resulting in a patient receiving the wrong medication or an incorrect dose.
Recalled due to missing labeling on some vials.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.